The role of ERα is somewhat controversial; despite overall lower levels of expression in some lung cancers, some studies have shown cytoplasmic ERα in non-small cell lung cancer (NSCLC), potentially due to a transcript variant [53,54]. Here, ESR1 is linked to non-small cell lung carcinoma.